Literature DB >> 18299912

Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm.

Emmanuel Mandonnet1, Johan Pallud, Olivier Clatz, Luc Taillandier, Ender Konukoglu, Hugues Duffau, Laurent Capelle.   

Abstract

The advent of magnetic resonance imaging (MRI) has allowed the follow-up of tumor growth by precise volumetric measurements. Such information about tumor dynamics is, however, usually not fully integrated in the therapeutic management, and the assessment of tumor evolution is still limited to qualitative description. In parallel, computational models have been developed to simulate in silico tumor growth and treatment efficacy. Nevertheless, direct clinical interest of these models remains questionable, and there is a gap between scientific advances and clinical practice. In this paper, WHO grade II glioma will serve as a paradigmatic example to illustrate that computational models allow characterizing tumor dynamics from serial MRIs. The role of these dynamics for both therapeutic management and biological research will be discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18299912     DOI: 10.1007/s10143-008-0128-6

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  29 in total

1.  Measurement of tumor "size" in recurrent malignant glioma: 1D, 2D, or 3D?

Authors:  Mary F Dempsey; Barrie R Condon; Donald M Hadley
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

2.  Extension of paralimbic low grade gliomas: toward an anatomical classification based on white matter invasion patterns.

Authors:  Emmanuel Mandonnet; Laurent Capelle; Hugues Duffau
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.130

3.  Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria.

Authors:  C Daumas-Duport; M L Tucker; H Kolles; P Cervera; F Beuvon; P Varlet; N Udo; M Koziak; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

4.  Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases.

Authors:  C Daumas-Duport; P Varlet; M L Tucker; F Beuvon; P Cervera; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

5.  Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study.

Authors:  E Shaw; R Arusell; B Scheithauer; J O'Fallon; B O'Neill; R Dinapoli; D Nelson; J Earle; C Jones; T Cascino; D Nichols; R Ivnik; R Hellman; W Curran; R Abrams
Journal:  J Clin Oncol       Date:  2002-05-01       Impact factor: 44.544

6.  Low grade glioma: a measuring radiographic response to radiotherapy.

Authors:  G Bauman; P Pahapill; D Macdonald; B Fisher; C Leighton; G Cairncross
Journal:  Can J Neurol Sci       Date:  1999-02       Impact factor: 2.104

7.  Estimation of rate of growth of malignant brain tumors by computed tomography scanning.

Authors:  T Yamashita; T Kuwabara
Journal:  Surg Neurol       Date:  1983-12

8.  The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas.

Authors:  M S Berger; A V Deliganis; J Dobbins; G E Keles
Journal:  Cancer       Date:  1994-09-15       Impact factor: 6.860

9.  Dynamic history of low-grade gliomas before and after temozolomide treatment.

Authors:  Damien Ricard; Gentian Kaloshi; Alexandra Amiel-Benouaich; Julie Lejeune; Yannick Marie; Emmanuel Mandonnet; Michèle Kujas; Karima Mokhtari; Sophie Taillibert; Florence Laigle-Donadey; Antoine F Carpentier; Antonio Omuro; Laurent Capelle; Hugues Duffau; Philippe Cornu; Rémy Guillevin; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

10.  The influence of volumetric tumor doubling time, DNA ploidy, and histologic grade on the survival of patients with intracranial astrocytomas.

Authors:  F G Blankenberg; R L Teplitz; W Ellis; M S Salamat; B H Min; L Hall; D B Boothroyd; I M Johnstone; D R Enzmann
Journal:  AJNR Am J Neuroradiol       Date:  1995-05       Impact factor: 3.825

View more
  32 in total

1.  Improving the time-machine: estimating date of birth of grade II gliomas.

Authors:  C Gerin; J Pallud; B Grammaticos; E Mandonnet; C Deroulers; P Varlet; L Capelle; L Taillandier; L Bauchet; H Duffau; M Badoual
Journal:  Cell Prolif       Date:  2011-12-14       Impact factor: 6.831

2.  Dynamic imaging response following radiation therapy predicts long-term outcomes for diffuse low-grade gliomas.

Authors:  Johan Pallud; Jean-François Llitjos; Frédéric Dhermain; Pascale Varlet; Edouard Dezamis; Bertrand Devaux; Raphaëlle Souillard-Scémama; Nader Sanai; Maria Koziak; Philippe Page; Michel Schlienger; Catherine Daumas-Duport; Jean-François Meder; Catherine Oppenheim; François-Xavier Roux
Journal:  Neuro Oncol       Date:  2012-03-13       Impact factor: 12.300

Review 3.  IDH wild-type WHO grade II diffuse low-grade gliomas. A heterogeneous family with different outcomes. Systematic review and meta-analysis.

Authors:  Davide Tiziano Di Carlo; Hugues Duffau; Federico Cagnazzo; Nicola Benedetto; Riccardo Morganti; Paolo Perrini
Journal:  Neurosurg Rev       Date:  2018-06-26       Impact factor: 3.042

4.  Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.

Authors:  Johan Pallud; Marie Blonski; Emmanuel Mandonnet; Etienne Audureau; Denys Fontaine; Nader Sanai; Luc Bauchet; Philippe Peruzzi; Marc Frénay; Philippe Colin; Rémy Guillevin; Valérie Bernier; Marie-Hélène Baron; Jacques Guyotat; Hugues Duffau; Luc Taillandier; Laurent Capelle
Journal:  Neuro Oncol       Date:  2013-02-07       Impact factor: 12.300

5.  Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas.

Authors:  Catherine Gozé; Marie Blonski; Guillaume Le Maistre; Luc Bauchet; Edouard Dezamis; Philippe Page; Pascale Varlet; Laurent Capelle; Bertrand Devaux; Luc Taillandier; Hugues Duffau; Johan Pallud
Journal:  Neuro Oncol       Date:  2014-05-20       Impact factor: 12.300

Review 6.  Modeling tumor growth and treatment response based on quantitative imaging data.

Authors:  Thomas E Yankeelov; Nkiruka C Atuegwu; Natasha G Deane; John C Gore
Journal:  Integr Biol (Camb)       Date:  2010-07-02       Impact factor: 2.192

7.  Effect of neoadjuvant temozolomide upon volume reduction and resection of diffuse low-grade glioma.

Authors:  Jasmin Jo; Brian Williams; Mark Smolkin; Max Wintermark; Mark E Shaffrey; M Beatriz Lopes; David Schiff
Journal:  J Neurooncol       Date:  2014-07-20       Impact factor: 4.130

8.  Is the volume of low-grade glioma measurable and is it clinically relevant?

Authors:  Marc C Chamberlain
Journal:  Neuro Oncol       Date:  2014-06-20       Impact factor: 12.300

9.  Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex.

Authors:  Àlex Rovira; María Luz Ruiz-Falcó; Elena García-Esparza; Eduardo López-Laso; Alfons Macaya; Ignacio Málaga; Élida Vázquez; Josefina Vicente
Journal:  J Neurooncol       Date:  2014-04-27       Impact factor: 4.130

10.  Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patients.

Authors:  Marie Blonski; Johan Pallud; Catherine Gozé; Emmanuel Mandonnet; Valérie Rigau; Luc Bauchet; Michel Fabbro; Patrick Beauchesne; Marie-Hélène Baron; Denys Fontaine; Philippe Peruzzi; Amélie Darlix; Hugues Duffau; Luc Taillandier
Journal:  J Neurooncol       Date:  2013-03-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.